Literature DB >> 20809716

Germinoma with malignant transformation to nongerminomatous germ cell tumor.

Judith M Wong1, Susan N Chi, Karen J Marcus, Bat-Sheva Levine, Nicole J Ullrich, Shannon MacDonald, Mirna Lechpammer, Liliana C Goumnerova.   

Abstract

The authors describe the case of a young girl with suprasellar germinoma. Six weeks after this diagnosis, just prior to initiation of therapy, serum and CSF marker analysis revealed sudden and marked elevation of alpha-fetoprotein, indicating transformation of her germinoma to a nongerminomatous germ cell tumor. She underwent chemotherapy and radiation therapy per the national treatment approach for the new diagnosis, with subsequent return of her serum and CSF tumor markers to normal levels. To the authors' knowledge, this is the first case in the English-language literature of a nongerminomatous germ cell tumor resulting from conversion of germinoma at the original site of presentation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809716     DOI: 10.3171/2010.6.PEDS09541

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  4 in total

1.  Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors.

Authors:  Hirokazu Takami; Shintaro Fukushima; Kohei Fukuoka; Tomonari Suzuki; Takaaki Yanagisawa; Yuko Matsushita; Taishi Nakamura; Hideyuki Arita; Akitake Mukasa; Nobuhito Saito; Masayuki Kanamori; Toshihiro Kumabe; Teiji Tominaga; Keiichi Kobayashi; Motoo Nagane; Toshihiko Iuchi; Kaoru Tamura; Taketoshi Maehara; Kazuhiko Sugiyama; Mitsutoshi Nakada; Yonehiro Kanemura; Masahiro Nonaka; Kiyotaka Yokogami; Hideo Takeshima; Yoshitaka Narita; Soichiro Shibui; Yoichi Nakazato; Ryo Nishikawa; Koichi Ichimura; Masao Matsutani
Journal:  J Neurooncol       Date:  2015-05-21       Impact factor: 4.130

2.  Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.

Authors:  J N Jeyapalan; D A Mohamed Noor; S-H Lee; C L Tan; V A Appleby; J P Kilday; R D Palmer; E C Schwalbe; S C Clifford; D A Walker; M J Murray; N Coleman; J C Nicholson; P J Scotting
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

3.  Elovl6 is a poor prognostic predictor in breast cancer.

Authors:  Yin-Hsun Feng; Wei-Yu Chen; Yu-Hsuan Kuo; Chao-Ling Tung; Chao-Jung Tsao; Ai-Li Shiau; Chao-Liang Wu
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

4.  Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling.

Authors:  Xiangyang Tian; Shuyuan Li; Guoyan Ge
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.